NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
10/25/2022
Back to search
Official data from USPTO
CASTLE CREEK BIOSCIENCES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
CASTLE CREEK BIOSCIENCES
ST13
US500000090498064Class
42
Filing
90498064
Registration
6675782
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
10/25/2022
Classification
Registered
Trademark type
Word
Nice classes
42
Filing date
01/29/2021
Registration date
03/22/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/22/2022
Last transaction
09/14/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2020-03-00
First use in commerce
2020-03-00
Drawing code
4
Owner type
16
Owner location
Exton, PA
Examiner
OJEYEMI, ASHLEY
Law office
O10
Current location
POST REGISTRATION
Holders and representatives
Holders
Castle Creek Biosciences, LLC
Representatives
Edward F. Behm, Jr. Armstrong Teasdale LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific research and developmentresearch and development of pharmaceutical and medical preparations for skin diseasesconnective tissue diseasesarthritis and autoimmune diseases; scientific research and development of therapeutics and procedures for skin diseasesconnective tissue diseasesarthritis and autoimmune diseases; scientific research and development of preparations and therapeutics
Publications
History of USPTO decisions and trademark events.
28 publications found
CORV
REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD
09/19/2022
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
09/19/2022
PLGL
ASSIGNED TO PARALEGAL
09/19/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/14/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/14/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
09/14/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/14/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/14/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/14/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/30/2022
ES7R
TEAS SECTION 7 REQUEST RECEIVED
03/30/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
03/22/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/04/2022
PUBO
PUBLISHED FOR OPPOSITION
01/04/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/15/2021
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/01/2021
ALIE
ASSIGNED TO LIE
11/30/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/30/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/19/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/18/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/18/2021
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
08/25/2021
GPRA
PRIORITY ACTION E-MAILED
08/25/2021
CPRA
PRIORITY ACTION WRITTEN
08/25/2021
DOCK
ASSIGNED TO EXAMINER
08/18/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/01/2021
NWAP
NEW APPLICATION ENTERED
02/02/2021
Continuous trademark protection
Get notified about every new filing that threatens CASTLE CREEK BIOSCIENCES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.